Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07279363 · ClinicalTrials.gov registry record · NA

Deaf CBT-TS to Reduce Suicide Risk

A NA study, sponsored by University of Rochester.

Not yet
Registry status
NA
Development phase
110
Enrollment target

NCT07279363 is a NA study that has not yet begun recruiting, run by University of Rochester. The registered enrollment target is 110 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07279363, a NA study, has not yet begun recruiting, sponsored by University of Rochester.

NOT YET RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn if a short, Zoom-based intervention, Cognitive Behavioral Therapy for Treatment-Seeking for Deaf Individuals (Deaf CBT-TS) can change beliefs about mental health treatment and increase treatment-seeking behaviors in Deaf adults with untreated mental health or alcohol use problems. It will also see if Deaf CBT-TS may reduce suicide risk and explore factors that may increase the effectiveness of Deaf CBT-TS. The main questions it aims to answer are: * Does Deaf CBT-TS increase positive beliefs about treatment and increase treatment-seeking behaviors? * Does Deaf CBT-TS increase hope and reduce mental health symptoms, suicide ideation, and alcohol use? * Is Deaf CBT-TS more effective for individuals with less cultural stress compared to those with high levels of cultural stress? * Is Deaf CBT-TS more effective for Deaf individuals in residential areas with more Deaf resources than those with less Deaf resources? Researchers will compare individuals who complete Deaf CBT-TS to those on a waitlist to see if Deaf CBT-TS works to increase positive beliefs about treatment and treatment-seeking behaviors. Participants will: * Complete a baseline assessment including demographic information, measures of hope, general mental health and functioning, alcohol use, suicide ideation, cultural stress, and beliefs about treatment. * Receive Deaf CBT-TS (2 sessions) or be placed on a waitlist with the option of receiving Deaf CBT-Ts after 4 months * Complete two follow-up assessments in 2 and 4 months.

Interventions

  • BEHAVIORAL Deaf CBT-TS

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2026-09
Est. Completion 2029-05
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT07279363

The ClinicalTrials.gov registry entry for NCT07279363 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Deaf CBT-TS is the first listed.

NCT07279363 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07279363 about?

NCT07279363 is a clinical study titled "Deaf CBT-TS to Reduce Suicide Risk". The goal of this clinical trial is to learn if a short, Zoom-based intervention, Cognitive Behavioral Therapy for Treatment-Seeking for Deaf Individuals (Deaf CBT-TS) can change beliefs about mental health treatment and increase treatment-seeking behaviors in Deaf adults with untreated mental health...

What is the current status of trial NCT07279363?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2026-09. Estimated completion is 2029-05.

What interventions are being tested in trial NCT07279363?

The interventions under investigation include: Deaf CBT-TS (BEHAVIORAL).

Who is sponsoring clinical trial NCT07279363?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.